Business philosophy of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.

In the scientific development, Zhenbaodao Pharmaceutical adheres to the research and development direction of scientific research and technological innovation, vigorously implements the strategy of scientific and technological innovation, and strengthens the in-depth study of the basic theory of traditional Chinese medicine. Establish and improve the investment, research and development, transformation and application mechanism of technological innovation, and form a technological innovation system with enterprises as the main body, market as the guidance and Industry-University-Research as the combination; In the process of optimizing the allocation of scientific and technological resources, a provincial standard modern medical laboratory was established. With the participation and cooperation of universities and scientific research institutions, basic research, pre-research, engineering technology research and applied research have been carried out in depth, which has accelerated the effective combination of traditional medicine and modern science and technology and achieved a major technological breakthrough in improving and improving the quality standards of traditional Chinese medicine injections. Under the guidance of the marketing concept of "creating demand and leading the market", we will vigorously implement the brand management strategy. By improving the internal quality and taste of the enterprise, increasing the control ability of the terminal market, we have cultivated large varieties with annual sales of over 100 million, such as Shuxuening injection and Xuesaitong for injection, and realized the strategic expansion of the market. It has improved the core competitiveness of enterprises and established a leading position in the market.

In order to promote the sustained and healthy development of enterprises, we vigorously implement the strategy of strengthening enterprises through talents, constantly innovate the talent development mechanism and optimize the talent development environment. Actively explore the channels of talent resources with outstanding students in colleges and universities as the left, and vigorously promote the professionalization, marketization and specialization of talents. At present, a group of scientific and technological talents with master's and doctor's degrees and rich practical experience have become leaders in various fields and disciplines of enterprises. In the process of diversified and multi-wheel-driven development strategy, it actively extended to related industries and established a complete pharmaceutical industry chain. Through capital operation, the company has promoted the transformation to shareholding system, diversification and securitization. According to the requirements of the new GMP, the company has strengthened the quality management in the whole process of production and operation. In order to ensure the safety of drugs, the company has invested hundreds of millions of yuan in Yunnan, Jiangsu and other places to establish GAP medicinal planting bases for Panax notoginseng and Ginkgo biloba, which has ensured the quality of drugs and the legitimacy of the sources of raw materials needed for drug production from the source. In the process of drug production, the automatic online monitoring of traditional Chinese medicine extraction and the automatic quality monitoring of the whole process of preparation production have been realized, and the early warning mechanism has been effectively implemented. Strict quality risk management mechanism is fully implemented from production, sales, circulation to clinical application, and it is completely controllable from production to market terminal to ensure the safety, effectiveness and controllability of public medication.